Recardio's Series A Round

Recardio raised a round of funding on November 11, 2015.

Recardio (REgenerative CARDIOvascular Therapy), founded in 2011, is a life science company that focuses on drug based regenerative therapeutic modalities for the treatment of cardiovascular diseases. …

Articles about Recardio's Series A Round: